ID: ALA1793967

Max Phase: Preclinical

Molecular Formula: C33H45N5O6

Molecular Weight: 607.75

Molecule Type: Protein

Representations

Canonical SMILES:  CCC(=O)CCCCC[C@@H]1NC(=O)[C@H]2CCCCN2C(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](C(=O)c2c[nH]c3ccccc23)NC1=O

Standard InChI:  InChI=1S/C33H45N5O6/c1-4-20(3)27-33(44)38-18-12-11-17-26(38)31(42)35-25(16-8-6-7-13-21(39)5-2)30(41)37-28(32(43)36-27)29(40)23-19-34-24-15-10-9-14-22(23)24/h9-10,14-15,19-20,25-28,34H,4-8,11-13,16-18H2,1-3H3,(H,35,42)(H,36,43)(H,37,41)/t20-,25-,26+,27-,28-/m0/s1

Standard InChI Key:  OHZAUIQSIDAXOV-MBHAOSHPSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Protein

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 607.75

Molecular Weight (Monoisotopic): 607.3370

AlogP: 3.18

#Rotatable Bonds: 11

Polar Surface Area: 157.54

Molecular Species: NEUTRAL

HBA: 6

HBD: 4

#RO5 Violations: 1

HBA (Lipinski): 11

HBD (Lipinski): 4

#RO5 Violations (Lipinski): 2

CX Acidic pKa: 10.45

CX Basic pKa:

CX LogP: 3.19

CX LogD: 3.19

Aromatic Rings: 2

Heavy Atoms: 44

QED Weighted: 0.17

Np Likeness Score: 0.84

References

1. Colletti SL, Myers RW, Darkin-Rattray SJ, Gurnett AM, Dulski PM, Galuska S, Allocco JJ, Ayer MB, Li C, Lim J, Crumley TM, Cannova C, Schmatz DM, Wyvratt MJ, Fisher MH, Meinke PT..  (2001)  Broad spectrum antiprotozoal agents that inhibit histone deacetylase: structure-activity relationships of apicidin. Part 2.,  11  (2): [PMID:11206439] [10.1016/s0960-894x(00)00605-3]

Source

Source(1):

• Scientific Literature